QUOTIENT LTD (QTNT) Stock Fundamental Analysis
NASDAQ:QTNT - Nasdaq - JE00BNNSZY03 - Common Stock - Currency: USD
Taking everything into account, QTNT scores 1 out of 10 in our fundamental rating. QTNT was compared to 189 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of QTNT have multiple concerns. QTNT is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year QTNT has reported negative net income.
QTNT had a negative operating cash flow in the past year.
In the past 5 years QTNT always reported negative net income.
In the past 5 years QTNT always reported negative operating cash flow.
1.2 Ratios
The profitability ratios for QTNT are negative, so there is not much use analyzing them.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin and Operating Margin and Gross Margin are not available for QTNT so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
QTNT does not have a ROIC to compare to the WACC, probably because it is not profitable.
QTNT has more shares outstanding than it did 1 year ago.
The debt/assets ratio for QTNT is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of -11.49, we must say that QTNT is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -11.49, QTNT is doing worse than 84.93% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -11.49 |
ROIC/WACCN/A
WACC8.48%
2.3 Liquidity
A Current Ratio of 1.79 indicates that QTNT should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.79, QTNT is doing worse than 79.00% of the companies in the same industry.
A Quick Ratio of 1.36 indicates that QTNT should not have too much problems paying its short term obligations.
QTNT's Quick ratio of 1.36 is on the low side compared to the rest of the industry. QTNT is outperformed by 74.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.79 | ||
| Quick Ratio | 1.36 |
3. Growth
3.1 Past
QTNT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -11.79%.
Looking at the last year, QTNT shows a small growth in Revenue. The Revenue has grown by 1.85% in the last year.
QTNT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.62% yearly.
EPS 1Y (TTM)-11.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-0.09%
Revenue 1Y (TTM)1.85%
Revenue growth 3Y9.76%
Revenue growth 5Y11.62%
Sales Q2Q%-6.45%
3.2 Future
Based on estimates for the next years, QTNT will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.78% on average per year.
QTNT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.13% yearly.
EPS Next Y44.75%
EPS Next 2Y31.45%
EPS Next 3Y16.98%
EPS Next 5Y14.78%
Revenue Next Year6.8%
Revenue Next 2Y21.99%
Revenue Next 3Y19.62%
Revenue Next 5Y16.13%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for QTNT. In the last year negative earnings were reported.
Also next year QTNT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
QTNT's earnings are expected to grow with 16.98% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.45%
EPS Next 3Y16.98%
5. Dividend
5.1 Amount
No dividends for QTNT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
0.38
+0.01 (+2.73%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners1.2%
Inst Owner Change0%
Ins Owners71.36%
Ins Owner Change0%
Market Cap1.29M
Analysts85.71
Price Target61.2 (16005.26%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-212.08%
Min EPS beat(2)-229.77%
Max EPS beat(2)-194.39%
EPS beat(4)0
Avg EPS beat(4)-157.49%
Min EPS beat(4)-229.77%
Max EPS beat(4)-82.98%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-19.74%
Min Revenue beat(2)-21.78%
Max Revenue beat(2)-17.7%
Revenue beat(4)1
Avg Revenue beat(4)-11.06%
Min Revenue beat(4)-21.78%
Max Revenue beat(4)3.88%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-33.33%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-3437.42%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.61%
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.03 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-53.21
EYN/A
EPS(NY)-13.06
Fwd EYN/A
FCF(TTM)-37.36
FCFYN/A
OCF(TTM)-36.7
OCFYN/A
SpS11.08
BVpS-53.62
TBVpS-53.74
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.29
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 34.49% | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.79 | ||
| Quick Ratio | 1.36 | ||
| Altman-Z | -11.49 |
F-Score2
WACC8.48%
ROIC/WACCN/A
Cap/Depr(3y)41.7%
Cap/Depr(5y)74.02%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-11.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-0.09%
EPS Next Y44.75%
EPS Next 2Y31.45%
EPS Next 3Y16.98%
EPS Next 5Y14.78%
Revenue 1Y (TTM)1.85%
Revenue growth 3Y9.76%
Revenue growth 5Y11.62%
Sales Q2Q%-6.45%
Revenue Next Year6.8%
Revenue Next 2Y21.99%
Revenue Next 3Y19.62%
Revenue Next 5Y16.13%
EBIT growth 1Y-27.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year21.41%
EBIT Next 3Y12.08%
EBIT Next 5Y4.76%
FCF growth 1Y-74.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-81.8%
OCF growth 3YN/A
OCF growth 5YN/A